We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Government Pauses Kodak Drug Ingredient Manufacturing Deal
U.S. Government Pauses Kodak Drug Ingredient Manufacturing Deal
The U.S. government’s $765 million loan to Eastman Kodak for a generic drug ingredient manufacturing facility aimed at reducing U.S. dependence on imports is on hold as federal investigators look into allegations of wrongdoing at the company.